S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
Log in
NASDAQ:SILK

Silk Road Medical Stock Forecast, Price & News

$62.17
-0.53 (-0.85 %)
(As of 01/21/2021 04:30 PM ET)
Add
Compare
Today's Range
$61.19
Now: $62.17
$63.33
50-Day Range
$55.02
MA: $60.08
$64.71
52-Week Range
$20.84
Now: $62.17
$75.80
Volume237,934 shs
Average Volume472,518 shs
Market Capitalization$2.11 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.41
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.

MarketRank

Overall MarketRank

0.88 out of 5 stars

Medical Sector

1059th out of 1,926 stocks

Surgical & Medical Instruments Industry

101st out of 169 stocks

Analyst Opinion: 1.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SILK
CUSIPN/A
CIKN/A
Phone408-720-9002
Employees224

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$63.35 million
Book Value$2.33 per share

Profitability

Net Income$-52,420,000.00

Miscellaneous

Market Cap$2.11 billion
Next Earnings Date2/24/2021 (Estimated)
OptionableNot Optionable
$62.17
-0.53 (-0.85 %)
(As of 01/21/2021 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SILK News and Ratings via Email

Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

How has Silk Road Medical's stock price been impacted by Coronavirus?

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SILK shares have increased by 67.4% and is now trading at $62.17.
View which stocks have been most impacted by COVID-19
.

Is Silk Road Medical a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Silk Road Medical stock.
View analyst ratings for Silk Road Medical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Silk Road Medical?

Wall Street analysts have given Silk Road Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Silk Road Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as Silk Road Medical's CEO?

1,448 employees have rated Silk Road Medical CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Silk Road Medical's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Silk Road Medical
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings results on Tuesday, November, 10th. The company reported ($0.31) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.28) by $0.03. The firm had revenue of $20.07 million for the quarter, compared to the consensus estimate of $18.99 million. Silk Road Medical had a negative return on equity of 40.79% and a negative net margin of 53.66%. The company's quarterly revenue was up 17.9% compared to the same quarter last year. During the same quarter last year, the company earned ($0.26) earnings per share.
View Silk Road Medical's earnings history
.

What price target have analysts set for SILK?

4 equities research analysts have issued 1-year price objectives for Silk Road Medical's stock. Their forecasts range from $55.00 to $75.00. On average, they anticipate Silk Road Medical's share price to reach $64.75 in the next year. This suggests a possible upside of 4.1% from the stock's current price.
View analysts' price targets for Silk Road Medical
or view Wall Street analyst' top-rated stocks.

Who are some of Silk Road Medical's key competitors?

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), The Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), Honeywell International (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the following people:
  • Ms. Erica J. Rogers, Pres, CEO & Director (Age 57, Pay $944.91k)
  • Mr. Lucas W. Buchanan, CFO & COO (Age 44, Pay $755.78k)
  • Mr. Andrew S. Davis, Chief Commercial Officer (Age 52, Pay $883.92k)
  • Ms. Mhairi L. Jones, VP of Fin. & Accounting
  • Mr. Matthew McCarthy, VP of Marketing
  • Ms. Alison Highlander, VP of HR
  • Dr. Sumaira MacDonald, Exec. Medical Director
  • Mr. Richard M. Reudy, Exec. VP of Clinical & Regulatory Affairs and Quality Assurance (Age 54)
  • Dr. William Whealon Ph.D., Exec. VP of R&D
  • Lynn Lewis, Investors Relations Officer

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Frontier Capital Management Co. LLC (1.49%), Peregrine Capital Management LLC (1.04%), Rhenman & Partners Asset Management AB (0.37%), Kestra Advisory Services LLC (0.02%) and ProVise Management Group LLC (0.02%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and X Finance LP Wp.
View institutional ownership trends for Silk Road Medical
.

Which major investors are selling Silk Road Medical stock?

SILK stock was sold by a variety of institutional investors in the last quarter, including Rhenman & Partners Asset Management AB, and ProVise Management Group LLC. Company insiders that have sold Silk Road Medical company stock in the last year include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, and Pincus & Co Warburg.
View insider buying and selling activity for Silk Road Medical
or view top insider-selling stocks.

Which major investors are buying Silk Road Medical stock?

SILK stock was acquired by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Peregrine Capital Management LLC, and Kestra Advisory Services LLC.
View insider buying and selling activity for Silk Road Medical
or or view top insider-buying stocks.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $62.17.

How big of a company is Silk Road Medical?

Silk Road Medical has a market capitalization of $2.11 billion and generates $63.35 million in revenue each year. The company earns $-52,420,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. Silk Road Medical employs 224 workers across the globe.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is www.silkroadmed.com.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.